| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |